North America Infectious Disease Diagnostics Market
North America Infectious Disease Diagnostics Market - By Type: Molecular Diagnostics, Immunoassays, Microbial Culture, Others; By Pathogen: Bacteria, Viruses, Fungi, Others; By Application: Hospital Laboratories, Diagnostic Centers, Point of Care Testing; By Country: USA and Canada
8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8.2 North America Infectious Disease Diagnostics Market - Opportunity Analysis Index,
By Type,
By Pathogen,
By Application,
and Region, 2024 - 2031
9. North America North America Infectious Disease Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.1.1 Molecular Diagnostics
9.1.2 Immunoassays
9.1.3 Microbial Culture
9.1.4 Others
9.2 By Pathogen Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.2.1 Bacteria
9.2.2 Viruses
9.2.3 Fungi
9.2.4 Others
9.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.3.1 Hospital Laboratories
9.3.2 Diagnostic Centers
9.3.3 Point of Care Testing
9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.4.1 United States
9.4.2 Canada
9.5 North America
North America Infectious Disease Diagnostics Market – Opportunity Analysis Index,
By Type,
By Pathogen,
By Application,
and Country, 2024 - 2031
9.6 Regional Trends Analysis
9.7 North America North America Infectious Disease Diagnostics Market Research Report - Company Profiles
9.7.1 Company 1 (United States)
9.7.2 Company 2 (Canada)
9.7.3 Company 3 (Canada)
10. Competition Landscape
10.1 Strategic Dashboard of Top Market Players
10.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
10.2.1 Abbott Laboratories
10.2.2 F. Hoffmann-La Roche Ltd.
10.2.3 bioMérieux SA
10.2.4 Thermo Fisher Scientific Inc.
10.2.5 Becton
10.2.6 Dickinson and Company
11. Data Collection Method and Research Approach 12. Principal Presumptions and Acronyms
Methodology & Credibility
Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.